These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 9078197)

  • 21. Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.
    Sanders GD; Hlatky MA; Every NR; McDonald KM; Heidenreich PA; Parsons LS; Owens DK
    Ann Intern Med; 2001 Nov; 135(10):870-83. PubMed ID: 11712877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Norris RM
    Lancet; 1997 Jun; 349(9067):1767. PubMed ID: 9193396
    [No Abstract]   [Full Text] [Related]  

  • 23. [Amiodarone and secondary prevention. The EMIAT study].
    Munoz A
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():67-9. PubMed ID: 1726998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can antiarrhythmic drugs survive survival trials?
    Pratt CM; Waldo AL; Camm AJ
    Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
    Lazzara R
    Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mishaps with anti-arrhythmic agents used to reduce mortality after infarction].
    Funck-Brentano C
    Rev Prat; 1992 Nov; 42(17):2175-8. PubMed ID: 1290040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function.
    Pfisterer M; Kiowski W; Burckhardt D; Follath F; Burkart F
    Am J Cardiol; 1992 Jun; 69(17):1399-402. PubMed ID: 1590226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
    Singh SN; Fletcher RD; Fisher SG; Singh BN; Lewis HD; Deedwania PC; Massie BM; Colling C; Lazzeri D
    N Engl J Med; 1995 Jul; 333(2):77-82. PubMed ID: 7539890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Pinski SL
    Lancet; 1997 Jun; 349(9067):1768-9; author reply 1769-70. PubMed ID: 9193400
    [No Abstract]   [Full Text] [Related]  

  • 30. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
    Moss AJ; Zareba W; Hall WJ; Klein H; Wilber DJ; Cannom DS; Daubert JP; Higgins SL; Brown MW; Andrews ML;
    N Engl J Med; 2002 Mar; 346(12):877-83. PubMed ID: 11907286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-arrhythmia therapy after myocardial infarct: preliminary results of EMIAT and CAMIAT studies].
    Kuck KH
    Z Kardiol; 1996; 85 Suppl 6():107-13. PubMed ID: 9064953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Irvine J; Baker B; Smith J; Jandciu S; Paquette M; Cairns J; Connolly S; Roberts R; Gent M; Dorian P
    Psychosom Med; 1999; 61(4):566-75. PubMed ID: 10443767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.
    Waldo AL; Camm AJ; deRuyter H; Friedman PL; MacNeil DJ; Pauls JF; Pitt B; Pratt CM; Schwartz PJ; Veltri EP
    Lancet; 1996 Jul; 348(9019):7-12. PubMed ID: 8691967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.
    Hohnloser SH; Kuck KH; Dorian P; Roberts RS; Hampton JR; Hatala R; Fain E; Gent M; Connolly SJ;
    N Engl J Med; 2004 Dec; 351(24):2481-8. PubMed ID: 15590950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amiodarone: what have we learned from clinical trials?
    Naccarelli GV; Wolbrette DL; Dell'Orfano JT; Patel HM; Luck JC
    Clin Cardiol; 2000 Feb; 23(2):73-82. PubMed ID: 10676597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Management of patients with risk of sudden death. The amiodarone example].
    Djian J
    Arch Mal Coeur Vaiss; 1994 Jan; 87(1 Spec No):67-74. PubMed ID: 7944868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction.
    Pfisterer ME; Kiowski W; Brunner H; Burckhardt D; Burkart F
    Circulation; 1993 Feb; 87(2):309-11. PubMed ID: 8425280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis.
    Hallstrom AP; Wyse DG; McAnulty J; ;
    J Interv Card Electrophysiol; 2008 Dec; 23(3):159-66. PubMed ID: 18810620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term effect of amiodarone therapy following myocardial infarct in patients with complex ventricular arrhythmias].
    Kiowski W; Brunner H; Pfisterer M; Burckhardt D; Burkart F
    Schweiz Med Wochenschr; 1993 Mar; 123(12):533-6. PubMed ID: 8475360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.